Biotech · Public company · San Francisco, CA, US
Vir Biotechnology, Inc.
Ticker VIR · SEC CIK 0001706431
Track this companyFree. Adds Vir Biotechnology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials194 recruiting or active
Pipeline programs19From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline19
- ElebsiranPhase 3 · Viral HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- sotrovimabPhase 3 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- TobevibartPhase 3 · Viral HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- VIR-7831 (sotrovimab)Phase 3 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- PEG-IFNαPhase 2 · Hepatitis B, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 2 · Locally Advanced or Metastatic HER2-Expressing CancersClinicalTrials.gov · fetched Nov 12, 2026
- Sotrovimab (Gen1)Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Sotrovimab (Gen2)Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- VIR-2218Phase 2 · Hepatitis B, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- VIR-2482 (1200 mg)Phase 2 · Influenza AClinicalTrials.gov · fetched Nov 12, 2026
- VIR-2482 (450 mg)Phase 2 · Influenza AClinicalTrials.gov · fetched Nov 12, 2026
- VIR-3434Phase 2 · Hepatitis B, ChronicClinicalTrials.gov · fetched Nov 12, 2026
- VIR-5818Phase 2 · Locally Advanced or Metastatic HER2-Expressing CancersClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- VIR-1111Phase 1 · HIV I InfectionClinicalTrials.gov · fetched Nov 12, 2026
- VIR-2218Phase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- VIR-2218Phase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- VIR-3434Phase 1 · Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- VIR-5525Phase 1 · Solid Tumor MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials19
- Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jul 22, 2025ClinicalTrials.gov NCT06960395 · fetched Nov 12, 2026
- A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 12, 2025ClinicalTrials.gov NCT06903338 · fetched Nov 12, 2026
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerPHASE1 · RECRUITING · started Aug 10, 2023ClinicalTrials.gov NCT05997615 · fetched Nov 12, 2026
- A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218PHASE1 · COMPLETED · started Jun 1, 2023ClinicalTrials.gov NCT05844228 · fetched Nov 12, 2026
- A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza APHASE2 · TERMINATED · started Oct 30, 2022ClinicalTrials.gov NCT05567783 · fetched Nov 12, 2026
- Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434PHASE1 · COMPLETED · started Sep 21, 2022ClinicalTrials.gov NCT05484206 · fetched Nov 12, 2026
- To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing CancersPHASE1_PHASE2 · RECRUITING · started Apr 13, 2022ClinicalTrials.gov NCT05356741 · fetched Nov 12, 2026
- Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)PHASE1 · TERMINATED · started Mar 28, 2022ClinicalTrials.gov NCT05280717 · fetched Nov 12, 2026
- Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB StudyPHASE1 · TERMINATED · started Jan 25, 2022ClinicalTrials.gov NCT05135650 · fetched Nov 12, 2026
- Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19PHASE2 · TERMINATED · started Dec 16, 2021ClinicalTrials.gov NCT05124210 · fetched Nov 12, 2026
- Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionPHASE2 · COMPLETED · started Jul 11, 2021ClinicalTrials.gov NCT04856085 · fetched Nov 12, 2026
- A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian ParticipantsPHASE1 · COMPLETED · started Jul 6, 2021ClinicalTrials.gov NCT04988152 · fetched Nov 12, 2026
- Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19.PHASE3 · TERMINATED · started Jun 10, 2021ClinicalTrials.gov NCT04913675 · fetched Nov 12, 2026
- Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19PHASE2 · COMPLETED · started Feb 18, 2021ClinicalTrials.gov NCT04779879 · fetched Nov 12, 2026
- VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy VolunteersPHASE1 · COMPLETED · started Dec 28, 2020ClinicalTrials.gov NCT04725877 · fetched Nov 12, 2026
- A Virtual Prospective Study Exploring Activity Trackers and COVID-19 InfectionsCOMPLETED · started Nov 4, 2020ClinicalTrials.gov NCT04623138 · fetched Nov 12, 2026
- A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 IllnessPHASE2 · COMPLETED · started Oct 29, 2020ClinicalTrials.gov NCT04634409 · fetched Nov 12, 2026
- VIR-7831 for the Early Treatment of COVID-19 in OutpatientsPHASE2_PHASE3 · COMPLETED · started Aug 27, 2020ClinicalTrials.gov NCT04545060 · fetched Nov 12, 2026
- Sotrovimab Expanded Access Treatment Protocol (COVID-19)NO_LONGER_AVAILABLEClinicalTrials.gov NCT05235347 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 1, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 24, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 28, 2026 · fetched Nov 12, 2026